Tirzepatide pilot trial explores colorectal cancer risk biomarkers and prevention feasibility
Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
Abstract
A Phase 1 pilot trial is underway to assess tirzepatide's effects on colorectal cancer risk biomarkers and evaluate the feasibility of precision prevention.